Published in J Cell Biol on March 01, 1988
Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide. Mol Cell Biol (1991) 1.44
Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells. Proc Natl Acad Sci U S A (1990) 1.31
Constitutive expression of the urokinase plasminogen activator gene in murine RAW264 macrophages involves distal and 5' non-coding sequences that are conserved between mouse and pig. Nucleic Acids Res (1991) 1.24
Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion. J Cell Biol (1989) 1.14
Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol (1991) 1.10
Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes. J Exp Med (1988) 1.00
Multiple nuclear factors interact with promoter sequences of the urokinase-type plasminogen activator gene. Nucleic Acids Res (1988) 0.90
Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res (1991) 0.88
Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin. J Clin Invest (1993) 0.86
Dexamethasone decreases urokinase plasminogen activator mRNA stability in MAT 13762 rat mammary carcinoma cells. Br J Cancer (1993) 0.81
Expression of gp120 in mice evokes anxiety behavior: Co-occurrence with increased dendritic spines and brain-derived neurotrophic factor in the amygdala. Brain Behav Immun (2016) 0.76
Dexamethasone-induced plasminogen activator inhibitor: characterization, purification, and preparation of monoclonal antibodies. Arch Dermatol Res (1990) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci U S A (1980) 109.70
A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell (1986) 36.96
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature (1984) 24.45
Steroid receptor regulated transcription of specific genes and gene networks. Annu Rev Genet (1985) 10.62
The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys (1952) 9.50
Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res (1985) 8.64
Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene. Nature (1984) 7.57
Human metallothionein genes--primary structure of the metallothionein-II gene and a related processed gene. Nature (1982) 7.05
The construction of cosmid libraries which can be used to transform eukaryotic cells. Nucleic Acids Res (1982) 5.66
A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med (1978) 3.92
On the regulation and control of fibrinolysis. Edward Kowalski Memorial Lecture. Thromb Haemost (1980) 3.44
Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell (1976) 3.13
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors. J Cell Biol (1987) 2.63
Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol (1986) 2.44
Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J Biol Chem (1984) 2.22
Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. Proc Natl Acad Sci U S A (1983) 2.20
Biochemical actions of glucocorticoids on macrophages in culture. Specific inhibition of elastase, collagenase, and plasminogen activator secretion and effects on other metabolic functions. J Exp Med (1978) 2.18
Metallothionein mRNA induction in HeLa cells in response to zinc or dexamethasone is a primary induction response. Nature (1980) 2.18
The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain. Hoppe Seylers Z Physiol Chem (1982) 2.14
Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta (1985) 2.08
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblasts. EMBO J (1987) 1.98
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci U S A (1986) 1.85
Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. EMBO J (1986) 1.78
Glucocorticoids enhance stability of human growth hormone mRNA. Mol Cell Biol (1987) 1.77
Modulations of functional activity in differentiated macrophages are accompanied by early and transient increase or decrease in c-fos gene transcription. J Immunol (1987) 1.38
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem (1986) 1.33
Plasminogen activator inhibitor 2: regulation of gene transcription during phorbol ester-mediated differentiation of U-937 human histiocytic lymphoma cells. Mol Cell Biol (1987) 1.32
Plasminogen activators and their inhibitors in a human mammary cell line (HBL-100). Modulation by glucocorticoids. J Biol Chem (1986) 1.32
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J Cell Biol (1987) 1.32
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages. J Exp Med (1987) 1.24
Inhibition of protein synthesis in LLC-PK1 cells increases calcitonin-induced plasminogen-activator gene transcription and mRNA stability. Biochem J (1987) 1.21
Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator. Thromb Haemost (1985) 1.19
Plasminogen activator in the bursa of Fabricius: correlations with morphogenetic remodeling and cell migrations. Cell (1981) 1.18
Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells. Proc Natl Acad Sci U S A (1978) 1.18
Suppression of urokinase-type plasminogen activator mRNA levels in human fibrosarcoma cells and synovial fibroblasts by anti-inflammatory glucocorticoids. EMBO J (1986) 1.15
Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor. Biochem J (1985) 1.12
Glucocorticoid inhibition of transcription from episomal proopiomelanocortin gene promoter. Proc Natl Acad Sci U S A (1986) 1.12
Dexamethasone induction of an inhibitor of plasminogen activator in HTC hepatoma cells. J Biol Chem (1984) 1.10
Hormonal regulation of plasminogen activator in rat hepatoma cells. Mol Cell Biochem (1983) 1.08
Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region. J Biol Chem (1985) 1.07
The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. A cellular product which specifically inhibits plasminogen activation. J Biol Chem (1982) 1.06
Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids. Ann N Y Acad Sci (1981) 1.06
Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies. Mol Cell Endocrinol (1986) 1.05
Inhibition of glucocorticosteroid action in cultured L-929 mouse fibroblasts by RU 486, a new anti-glucocorticosteroid of high affinity for the glucocorticosteroid receptor. Exp Cell Res (1983) 1.03
The role of hemostasis and fibrinolysis in the metastatic spread of cancer. Semin Thromb Hemost (1984) 1.02
Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells. Mol Cell Biol (1987) 0.96
Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231. Cancer Res (1987) 0.95
Glucocorticoid-regulated expression from the 5'-flanking region of the rat alpha 1-acid glycoprotein gene. Requirement for ongoing protein synthesis. J Biol Chem (1987) 0.94
Human synovial fibroblast plasminogen activator. Modulation of enzyme activity by antiinflammatory steroids. Arthritis Rheum (1981) 0.91
Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators. Thromb Haemost (1985) 0.87
Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma. Cancer Res (1985) 0.85
Glucocorticoid inhibition of urokinase-like plasminogen activators in cultured human lymphoblasts. Endocrinology (1985) 0.84
Suppression of plasminogen activator activity by dexamethasone in cultured cardiac myocytes. J Mol Cell Cardiol (1986) 0.80
Dexamethasone coordinately inhibits plasminogen activator gene expression and enzyme activity in porcine kidney cells. Biochem Biophys Res Commun (1987) 0.78
Characterization of the cellular binding site for the urokinase-type plasminogen activator. J Biol Chem (1989) 1.93
Isolation and characterization of urokinase from human plasma. J Biol Chem (1982) 1.47
The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J Biol Chem (1990) 1.43
Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci U S A (1997) 1.38
Facultative polypeptide translocation allows a single mRNA to encode the secreted and cytosolic forms of plasminogen activators inhibitor 2. EMBO J (1989) 1.38
Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest (1997) 1.37
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem (1986) 1.33
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J Cell Biol (1987) 1.32
The human cysteine-rich secretory protein (CRISP) family. Primary structure and tissue distribution of CRISP-1, CRISP-2 and CRISP-3. Eur J Biochem (1996) 1.16
Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion. J Cell Biol (1989) 1.14
Triabin, a highly potent exosite inhibitor of thrombin. J Biol Chem (1995) 1.14
Primary structure and properties of helothermine, a peptide toxin that blocks ryanodine receptors. Biophys J (1995) 1.12
Plasminogen activators, plasminogen activator inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer (1986) 1.10
Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction. Eur J Biochem (1998) 1.08
Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region. J Biol Chem (1985) 1.07
Interaction of urokinase-type plasminogenactivator (u-PA) with its cellular receptor (u-PAR) induces phosphorylation on tyrosine of a 38 kDa protein. FEBS Lett (1993) 1.06
New androgen response elements in the murine pem promoter mediate selective transactivation. Mol Endocrinol (2001) 1.04
An inhibitor of collagen-induced platelet aggregation from the saliva of Triatoma pallidipennis. J Biol Chem (1994) 1.03
Plasminogen activator inhibitor 1 and 2 are tumor necrosis factor/cachectin-responsive genes. J Exp Med (1988) 1.00
Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion event. Hum Genet (1992) 0.99
Splice variants of the human EP3 receptor for prostaglandin E2. Eur J Biochem (1995) 0.98
Transcripts for cysteine-rich secretory protein-1 (CRISP-1; DE/AEG) and the novel related CRISP-3 are expressed under androgen control in the mouse salivary gland. Endocrinology (1993) 0.97
Complex-formation and inhibition of urokinase by blood plasma proteins. Biochem J (1983) 0.95
CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2. Mol Cell Biol (1996) 0.93
Androgen receptor signalling: comparative analysis of androgen response elements and implication of heat-shock protein 90 and 14-3-3eta. Mol Cell Endocrinol (2001) 0.91
Mouse androgen-dependent epididymal glycoprotein CRISP-1 (DE/AEG): isolation, biochemical characterization, and expression in recombinant form. Mol Reprod Dev (1995) 0.91
A general route to fingerprint analyses of peptide-antibody interactions using a clustered amino acid peptide library: comparison with a phage display library. Mol Immunol (1995) 0.90
Plasminogen activators, activation inhibitors and alpha 2-macroglobulin produced by cultured normal and malignant human cells. Int J Cancer (1984) 0.89
Chemical probes that differentially modulate peroxisome proliferator-activated receptor alpha and BLTR, nuclear and cell surface receptors for leukotriene B(4). J Biol Chem (1999) 0.89
Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid. Gene (1993) 0.88
Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis. Blood (1989) 0.88
Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int (1989) 0.88
Expression of high levels of human tissue plasminogen activator in yeast under the control of an inducible GAL promoter. Appl Microbiol Biotechnol (1992) 0.85
Control elements between -9.5 and -3.0 kb in the human tissue-type plasminogen activator gene promoter direct spatial and inducible expression to the murine brain. Eur J Neurosci (2001) 0.85
The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: cloning and expression. Gene (1991) 0.85
Some characteristics of highly purified boar sperm acrosin. Hoppe Seylers Z Physiol Chem (1974) 0.84
Human plasma prekallikrein. Immunoaffinity purification and activation to alpha- and beta-kallikrein. J Biol Chem (1986) 0.84
A proenzyme from chicken plasma similar to human plasma prekallikrein. J Biol Chem (1983) 0.84
Inhibition of acrosin by protein C inhibitor and localization of protein C inhibitor to spermatozoa. Am J Physiol (1994) 0.84
Expression of transcripts for cysteine-rich secretory proteins (CRISPs) in the murine lacrimal gland. J Cell Physiol (1999) 0.82
Differential androgen regulation of the murine genes for cysteine-rich secretory proteins (CRISP). Eur J Biochem (1997) 0.82
Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells. J Cell Physiol (1991) 0.82
Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells. FEBS Lett (1994) 0.82
cDNA cloning of two closely related forms of human germ cell nuclear factor (GCNF). Biochim Biophys Acta (1997) 0.81
Isolation and characterization of the androgen-dependent mouse cysteine-rich secretory protein-1 (CRISP-1) gene. Biochem J (1997) 0.81
Structural features mediating fibrin selectivity of vampire bat plasminogen activators. J Biol Chem (1995) 0.81
Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification. Biochem J (1985) 0.81
Molecular cloning of human endothelin (ET) receptors ETA and ETB. J Cardiovasc Pharmacol (1992) 0.80
Mutational analysis of human endothelin receptors ETA and ETB identification of regions involved in the selectivity for endothelin 3 or cyclo-(D-Trp-D-Asp-Pro-D-Val-Leu). Eur J Biochem (1994) 0.80
Purification of human big endothelin 1 derived through cleavage with collagenase and dipeptidylpeptidase IV from a fusion protein expressed in Escherichia coli. Protein Expr Purif (1994) 0.80
Induction of fibrinolytic activity in HeLa cells by phorbol myristate acetate. Tissue-type plasminogen activator antigen and mRNA augmentation require intermediate protein biosynthesis. J Biol Chem (1985) 0.80
Multiple forms of boar acrosin and their relationship to proenzyme activation. Hoppe Seylers Z Physiol Chem (1976) 0.80
Isolation and characterization of the androgen-dependent mouse cysteine-rich secretory protein-3 (CRISP-3) gene. Biochem J (1995) 0.80
Monoclonal antibodies directed against human tissue-type plasminogen activator: a characterization of their species specificity, affinity and heavy-chain binding. Thromb Res (1987) 0.79
Catalytic domain structure of vampire bat plasminogen activator: a molecular paradigm for proteolysis without activation cleavage. Biochemistry (1997) 0.79
Thrombolytic properties of Desmodus rotundus (vampire bat) salivary plasminogen activator in experimental pulmonary embolism in rats. Blood (1992) 0.79
Stable expression of human endothelin receptors ETA and ETB by transfected baby hamster kidney cells. Biochem Biophys Res Commun (1993) 0.79
Sperm acrosin. Methods Enzymol (1976) 0.79
Expression of active recombinant pallidipin, a novel platelet aggregation inhibitor, in the periplasm of Escherichia coli. Biochem J (1995) 0.78
Vessel-specific gene expression in the lung: tissue plasminogen activator expression is limited to bronchial arteries and pulmonary vessels of discrete size. Chest (1998) 0.78
Highly purified acrosomal proteinase (boar acrosin): isolation by affinity chromatography using benzamidine-cellulose and stabilization. Hoppe Seylers Z Physiol Chem (1973) 0.78
Urokinase-type plasminogen activator biosynthesis is induced by the EJ-Ha-ras oncogene in CL26 mouse colon carcinoma cells. Int J Cancer (1989) 0.78
Multiple forms of human acrosin: isolation and properties. Hoppe Seylers Z Physiol Chem (1976) 0.78
Tumor necrosis factor alpha increases antifibrinolytic activity of cultured human mesangial cells. Kidney Int (1992) 0.77
Extracellular cysteine residues 174 and 255 are essential for active expression of human endothelin receptor ETB in Escherichia coli. J Cardiovasc Pharmacol (1993) 0.77
Bibrotoxin, a novel member of the endothelin/sarafotoxin peptide family, from the venom of the burrowing asp Atractaspis bibroni. FEBS Lett (1993) 0.77
Boar acrosin, II: Amino acid composition, amino terminal residue and molecular weight estimations by ultracentrifugation. Hoppe Seylers Z Physiol Chem (1975) 0.77
Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells. Am J Pathol (1992) 0.77
Cleavage specificity of boar acrosin on polypeptide substrates, ribonuclease and insulin B-chain. Hoppe Seylers Z Physiol Chem (1975) 0.77
Proteinases and proteinase inhibitors in the fertilization process: new concepts of control? Adv Biosci (1973) 0.77
Expression of human endothelin receptor ETB by Escherichia coli transformants. Biochem Biophys Res Commun (1993) 0.77
Coronary thrombolysis with Desmodus salivary plasminogen activator in dogs. Fast and persistent recanalization by intravenous bolus administration. Circulation (1994) 0.76
Chromosomal findings and p53-mutation analysis in chromophilic renal-cell carcinomas. Int J Cancer (1996) 0.76
Occurrence of multiple forms of bull and ram acrosin during proenzyme activation and inhibition of activation by p-nitrophenyl p'-guanidinobenzoate. Hoppe Seylers Z Physiol Chem (1976) 0.76
Production of vampire bat plasminogen activator DSPA alpha 1 in CHO and insect cells. J Biotechnol (1995) 0.76
XmnI polymorphism in the human TPA gene. Nucleic Acids Res (1990) 0.75
Helodermatine, a kallikrein-like, hypotensive enzyme from the venom of Heloderma horridum horridum (Mexican beaded lizard). J Exp Med (1986) 0.75
Expression, purification and characterisation of recombinant pallidipin, a novel platelet aggregation inhibitor from the haematophageous triatomine bug Triatoma pallidipennis. Blood Coagul Fibrinolysis (1996) 0.75
Leiomyosarcoma in a patient with trisomy 8 mosaicism. J Med Genet (1991) 0.75
Detection of a TaqI polymorphism within the human TPA gene (PLAT). Nucleic Acids Res (1991) 0.75
Binding characteristics of recombinant human endothelin receptors ETA and ETB expressed in baby hamster kidney cells. J Cardiovasc Pharmacol (1993) 0.75
Schistonchus africanus n. sp. (Aphelenchida: Aphelenchoididae) Associated with Ficus thonningii (Moraceae) and its Pollinator Wasp Elisabethiella stuckenbergi (Chalcidoidea: Agaonidae). J Nematol (1998) 0.75
High-level secretion of the four salivary plasminogen activators from the vampire bat Desmodus rotundus by stably transfected baby hamster kidney cells. Gene (1992) 0.75
Rational design of hirulog-type inhibitors of thrombin. J Comput Aided Mol Des (1994) 0.75
Low-M(r) urokinase-type plasminogen activator as a reporter protein. Gene (1995) 0.75
Fibrin selectivity of the isolated protease domains of tissue-type and vampire bat salivary gland plasminogen activators. Eur J Biochem (1998) 0.75
Regulation of human tissue-type plasminogen activator gene transcription by epidermal growth factor and 3',5'-cyclic adenosine monophosphate. Mol Endocrinol (1991) 0.75
Activation and subsequent degradation of proacrosin is mediated by zona pellucida glycoproteins, negatively charged polysaccharides, and DNA. Mol Reprod Dev (1991) 0.75
Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells. Biochim Biophys Acta (1992) 0.75
[New thrombolytic and anticoagulant drugs from the saliva of blood-sucking animals]. Pharm Unserer Zeit (1995) 0.75
Boar acrosin, I: modified isolation procedure, active-site titration and evidence for the presence of sialic acid. Hoppe Seylers Z Physiol Chem (1975) 0.75